corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Updates

Healthy Skepticism Update 21 November 2010

HS International News issue: Public information as a marketing tool: Promotion of diseases and medicines
Sandra van Nuland and Zamire Damen work for Gezonde scepsis (Healthy Skepticism in The Netherlands). They have produced a report on pharmaceutical promotion via “information” for the general public. As part of this research, they examined campaigns around restless legs syndrome (RLS), overactive bladder (OAB) and heartburn. These three case studies demonstrate that elements of the public information are not in accordance with the guidelines set by the Dutch General Practitioners Society (NHG). For example, information about side effects and information about when medicinal intervention is warranted.

In collaboration with the Dutch critical consumer programme Tros Radar, a fake public information campaign around the issue of flatulence was designed, in order to demonstrate the mechanisms typically used in these campaigns and their effects on the public. They established a fictitious company with its own website (www.hetluchtop.nl, itclearstheair.nl), and commissioned TNS NIPO to carry out research into the disease burden. Promotional materials were prepared and distributed to GP surgeries, pharmacies and through the website. Based on the research conducted by TNS NIPO, they sent out a press release and quickly obtained the desired results: flatulence got a lot of attention in the media.

Read more at: www.healthyskepticism.org/global/news/int/hsin2010-11/


Survey: Your views on Healthy Skepticism
Already over 200 people have expressed a wide range of views about Healthy Skepticism via our brief anonymous survey. Your views are important to us so please express them at: www.surveymonkey.com/s/V9C9ZC6
We will be publishing a summary of the results with responses to many of the views expressed by our subscribers and members. We will use the results to help us set priorities for 2010.


New Book: The Risks of Prescription Drugs
We mentioned this book in the previous HS Update. Since then the editor Donald Light has told us that the best way to buy his book is from Amazon:
www.amazon.com/Risks-Prescription-Drugs-Columbia-Privatization/dp/0231146930/

 

Updates homepage

 

Comments

Our members can see and make comments on this page.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

  • E-mail
  • LinkedIn
  • Del.icio.us
  • Digg
  • Facebook
  • FriendFeed
  • Google Bookmarks
  • MySpace
  • Reddit
  • Slashdot
  • StumbleUpon
  • Tumblr
  • Twitter
  • Yahoo! Bookmarks








...to influence multinational corporations effectively, the efforts of governments will have to be complemented by others, notably the many voluntary organisations that have shown they can effectively represent society’s public-health interests…
A small group known as Healthy Skepticism; formerly the Medical Lobby for Appropriate Marketing) has consistently and insistently drawn the attention of producers to promotional malpractice, calling for (and often securing) correction. These organisations [Healthy Skepticism, Médecins Sans Frontières and Health Action International] are small, but they are capable; they bear malice towards no one, and they are inscrutably honest. If industry is indeed persuaded to face up to its social responsibilities in the coming years it may well be because of these associations and others like them.
- Dukes MN. Accountability of the pharmaceutical industry. Lancet. 2002 Nov 23; 360(9346)1682-4.